Die Frage der Qualifikation als Grundproblem des internationalen Privatrechts (Nr. 1 der « Zürcher Studien zum Internationalen Recht ») Werner Niederer H. Fritzsche D. Schindler

Publikováno v: Die Friedens-Warte, 1941 Jan 01. 41(1), 45-46.

Externí odkaz: https://www.jstor.org/stable/23774357

Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations.

Autor: Willoughby JE; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., Dou L; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., Bhattacharya S; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Jackson H; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Seestaller-Wehr L; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Kilian D; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Bover L; Immunology Department/ Genomics Medicine Department, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Voo KS; ORBIT, Institute of Applied Cancer Science, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Cox KL; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., Murray T; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., John M; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., Shi H; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Bojczuk P; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Jing J; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Niederer H; Biopharm Discovery, GlaxoSmithKline Research & Development Limited, Stevenage, UK., Shepherd AJ; Protein, Cellular and Structural Sciences, GlaxoSmithKline Research & Development Limited, Gunnels Wood Road, Stevenage, UK., Hook L; Biopharm Discovery, GlaxoSmithKline Research & Development Limited, Stevenage, UK., Hopley S; Biopharm Discovery, GlaxoSmithKline Research & Development Limited, Stevenage, UK., Inzhelevskaya T; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., Penfold CA; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., Mockridge CI; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., English V; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK., Brett SJ; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Srinivasan R; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Hopson C; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Smothers J; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Hoos A; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Paul E; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; GlaxoSmithKline, Durham, North Carolina, USA., Martin SL; Biopharm Discovery, GlaxoSmithKline Research & Development Limited, Stevenage, UK., Morley PJ; Immunology Research Unit, GlaxoSmithKline Research & Development Limited, Gunnels Wood Road, Stevenage, UK., Yanamandra N; Immuno-Oncology and Combinations RU, GlaxoSmithKline, Collegeville, Pennsylvania, USA msc@soton.ac.uk Niranjan.x.yanamandra@gsk.com., Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK msc@soton.ac.uk Niranjan.x.yanamandra@gsk.com.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 04; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 04.

A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters.

Autor: Shahpar, Amirhossein¹ (AUTHOR), Sofiani, Vahideh Hamidi² (AUTHOR), Nezhad, Nazanin Zeinali³ (AUTHOR), Charostad, Marzieh⁴ (AUTHOR), Ghaderi, Reza¹ (AUTHOR), Farsiu, Niloofar¹ (AUTHOR), Kiskani, Amin Karimzadeh⁵ (AUTHOR), Pezeshki, Sara⁶ (AUTHOR), Nakhaie, Mohsen^1,5 (AUTHOR) mohsennakhaee1367@gmail.com

Publikováno v: BMC Cancer. 10/29/2024, Vol. 24 Issue 1, p1-15. 15p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Thermally activated conductance of a silicon inversion layer by electrons excited above the mobility edge.

Autor: Niederer, H H J M, Mattey, A P M, Sparnaay, M J

Publikováno v: Journal of Physics C: Solid State Physics; 1981, Vol. 14 Issue 28, p4177-4184, 8p